Children's National receives $6 million for global polycystic kidney disease initiative
(Children's National Hospital) Lisa M. Guay-Woodford, MD, McGehee Joyce Professor of Pediatrics at Children's National Hospital, has received a $5.7 million dollar gift to support clinical and research activities. Polycystic kidney disease is a genetic disorder characterized by clusters of fluid-filled sacs (cysts) multiplying and interfering with the kidneys' ability to filter waste from the blood. The kidneys' smooth surface transforms to a bumpy texture as the essential organs grow oversized and riddled with cysts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2019 Category: International Medicine & Public Health Source Type: news
Kidney Swaps Are Revolutionizing a Broken Organ-Donation System in the U.S.
2017 ended as a banner year for my family, but things didn’t look great at the start. A death sentence met us in a boxing ring, and we had to school ourselves on fighting to live. I never thought much about the 37 million American adults who suffer from kidney disease until my husband Neil became one of them.
Celebrating our first year of marriage in 2001, we learned by accident through an unrelated medical exam that my husband has polycystic kidney disease, an illness which causes the kidneys to fill with cysts over time, rendering the organs unable to function properly. There is no cure. There was nothing to do but...
Source: TIME: Health - November 5, 2019 Category: Consumer Health News Authors: Lisa Emmott Tags: Uncategorized health Healthcare medicine public health Source Type: news
A promising treatment for an incurable, deadly kidney disease
A potential treatment for polycystic kidney disease - a genetic disorder that causes the kidneys to swell with multiple cysts and can eventually lead to organ failure - has shown promising results in animal testing. A study describing the drug's development and testing appears today in Nature Communications. The study shows an approximately 50 percent reduction in kidney size in afflicted mice following treatment. (Source: World Pharma News)
Source: World Pharma News - September 12, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Autosomal Dominant Polycystic Kidney Disease: Studies in Comorbidity
Studies on comorbidities seen with CKD reviewed here examine controlled vs uncontrolled gout, psychiatric diagnoses, and screening for intracranial aneurysm. (Source: ConsultantLive)
Source: ConsultantLive - September 6, 2019 Category: Internal Medicine Tags: Kidney Disease Source Type: news
Should ADPKD Patients Be Screened for Hidden Aneurysms? Should ADPKD Patients Be Screened for Hidden Aneurysms?
Screening patients with polycystic kidney disease who are at risk for brain aneurysms pays off, but current screening recommendations shouldn ' t be altered, say authors.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 1, 2019 Category: Neurology Tags: Nephrology News Source Type: news
Brain Aneurysm Risk Examined in Polycystic Kidney Disease
THURSDAY, Aug. 1, 2019 -- Intracranial aneurysms are detected in 9 percent of patients with autosomal dominant polycystic kidney disease (ADPKD) undergoing magnetic resonance angiography (MRA) screening, according to a study published online July 30... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 1, 2019 Category: Pharmaceuticals Source Type: news
Autosomal-dominant Polycystic Kidney Disease: 3 Studies in Brief
Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease. (Source: ConsultantLive)
Source: ConsultantLive - July 8, 2019 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Kidney Disease Source Type: news
KC charity will invest $5M to fund research into a cure for PKD
The PKD Foundation will invest nearly $5 million on research over the next two years to fund treatment studies and research polycystic kidney disease.
"For the past 36 years, our goal has been to support PKD patients from care to cure. With the support of generous donations, we have the ability to stand beside PKD patients until there is a cure, supporting research for new treatments and to support researchers," PKD Foundation CEO Andy Betts sai d in a news release.
The foundation announced that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 25, 2019 Category: Biotechnology Authors: Lily Lieberman Source Type: news
KC charity will invest $5M to fund research into a cure for PKD
The PKD Foundation will invest nearly $5 million on research over the next two years to fund treatment studies and research polycystic kidney disease.
"For the past 36 years, our goal has been to support PKD patients from care to cure. With the support of generous donations, we have the ability to stand beside PKD patients until there is a cure, supporting research for new treatments and to support researchers," PKD Foundation CEO Andy Betts sai d in a news release.
The foundation announced that… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 25, 2019 Category: American Health Authors: Lily Lieberman Source Type: news
Polycystic Kidney Disease (PKD)
Title: Polycystic Kidney Disease (PKD)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/17/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 17, 2019 Category: Nutrition Source Type: news
Too close not to encyst: Polycystic kidney disease and interorganellar contact sites
Mitofusin 2 (MFN2) tethers mitochondria to the endoplasmic reticulum (ER). In the 7 May 2019 issue of Science Signaling, Kuo et al. report that polycystin 2 (PC2), encoded by a gene mutated in type 2 autosomal dominant polycystic kidney disease (ADPKD), contributes to cystogenesis by affecting MFN2, thus extending the role of mitochondria-ER contact sites to a common genetic disorder. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - May 27, 2019 Category: Science Authors: Lorenzi, I., Scorrano, L. Tags: STKE Focus Source Type: news
Polycystic Kidney Disease: Studies on Obesity, Pain, Screening
Find summaries here of 3 recent studies conducted to shed light on difficult issues in the management of autosomal dominant polycystic kidney disease: (Source: ConsultantLive)
Source: ConsultantLive - May 10, 2019 Category: Internal Medicine Authors: Andrew Bowser Tags: Kidney Disease Source Type: news
New strategy for untreatable kidney disease: targeting cell energy
By targeting a protein called Polycystin 2, Yale researchers have identified a promising approach for treating autosomal dominant polycystic kidney disease. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 7, 2019 Category: Universities & Medical Training Source Type: news
Polycystic Kidney Disease: How Much Do You Know?
Autosomal dominant polycystic kidney disease us the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more. (Source: ConsultantLive)
Source: ConsultantLive - May 6, 2019 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Kidney Disease Source Type: news
Polycystic Kidney Disease: What & #039;s Your ADPKD IQ?
Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more. (Source: ConsultantLive)
Source: ConsultantLive - May 6, 2019 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Kidney Disease Source Type: news
